Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2006

Open Access 01-12-2006 | Original investigation

Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging

Authors: Rajprasad Loganathan, Mehmet Bilgen, Baraa Al-Hafez, Mohammed D Alenezy, Irina V Smirnova

Published in: Cardiovascular Diabetology | Issue 1/2006

Login to get access

Abstract

Background

Diabetes is a major risk factor for cardiovascular disease. In particular, type 1 diabetes compromises the cardiac function of individuals at a relatively early age due to the protracted course of abnormal glucose homeostasis. The functional abnormalities of diabetic myocardium have been attributed to the pathological changes of diabetic cardiomyopathy.

Methods

In this study, we used high field magnetic resonance imaging (MRI) to evaluate the left ventricular functional characteristics of streptozotocin treated diabetic Sprague-Dawley rats (8 weeks disease duration) in comparison with age/sex matched controls.

Results

Our analyses of EKG gated cardiac MRI scans of the left ventricle showed a 28% decrease in the end-diastolic volume and 10% increase in the end-systolic volume of diabetic hearts compared to controls. Mean stroke volume and ejection fraction in diabetic rats were decreased (48% and 28%, respectively) compared to controls. Further, dV/dt changes were suggestive of phase sensitive differences in left ventricular kinetics across the cardiac cycle between diabetic and control rats.

Conclusion

Thus, the MRI analyses of diabetic left ventricle suggest impairment of diastolic and systolic hemodynamics in this rat model of diabetic cardiomyopathy. Our studies also show that in vivo MRI could be used in the evaluation of cardiac dysfunction in this rat model of type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tziakas DN, Chalikias GK, Kaski JC: Epidemiology of the diabetic heart. Coron Artery Dis. 2005, 16 Suppl 1: S3-S10. 10.1097/00019501-200511001-00002.CrossRefPubMed Tziakas DN, Chalikias GK, Kaski JC: Epidemiology of the diabetic heart. Coron Artery Dis. 2005, 16 Suppl 1: S3-S10. 10.1097/00019501-200511001-00002.CrossRefPubMed
2.
go back to reference Hayat SA, Patel B, Khattar RS, Malik RA: Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond). 2004, 107 (6): 539-557.CrossRef Hayat SA, Patel B, Khattar RS, Malik RA: Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond). 2004, 107 (6): 539-557.CrossRef
3.
go back to reference Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004, 25 (4): 543-567. 10.1210/er.2003-0012.CrossRefPubMed Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004, 25 (4): 543-567. 10.1210/er.2003-0012.CrossRefPubMed
4.
go back to reference Fein FS, Sonnenblick EH: Diabetic cardiomyopathy. Prog Cardiovasc Dis. 1985, 27 (4): 255-270. 10.1016/0033-0620(85)90009-X.CrossRefPubMed Fein FS, Sonnenblick EH: Diabetic cardiomyopathy. Prog Cardiovasc Dis. 1985, 27 (4): 255-270. 10.1016/0033-0620(85)90009-X.CrossRefPubMed
5.
go back to reference Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001, 24 (1): 5-10.CrossRefPubMed Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001, 24 (1): 5-10.CrossRefPubMed
6.
go back to reference Vallee JP, Ivancevic MK, Nguyen D, Morel DR, Jaconi M: Current status of cardiac MRI in small animals. Magma. 2004, 17 (3-6): 149-156. 10.1007/s10334-004-0066-4.CrossRefPubMed Vallee JP, Ivancevic MK, Nguyen D, Morel DR, Jaconi M: Current status of cardiac MRI in small animals. Magma. 2004, 17 (3-6): 149-156. 10.1007/s10334-004-0066-4.CrossRefPubMed
7.
go back to reference Al-Shafei AI, Wise RG, Gresham GA, Bronns G, Carpenter TA, Hall LD, Huang CL: Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol. 2002, 538 (Pt 2): 541-553. 10.1113/jphysiol.2001.012856.PubMedCentralCrossRefPubMed Al-Shafei AI, Wise RG, Gresham GA, Bronns G, Carpenter TA, Hall LD, Huang CL: Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol. 2002, 538 (Pt 2): 541-553. 10.1113/jphysiol.2001.012856.PubMedCentralCrossRefPubMed
8.
go back to reference Al-Shafei AI, Wise RG, Gresham GA, Carpenter TA, Hall LD, Huang CL: Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition. J Physiol. 2002, 538 (Pt 2): 555-572. 10.1113/jphysiol.2001.012857.PubMedCentralCrossRefPubMed Al-Shafei AI, Wise RG, Gresham GA, Carpenter TA, Hall LD, Huang CL: Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition. J Physiol. 2002, 538 (Pt 2): 555-572. 10.1113/jphysiol.2001.012857.PubMedCentralCrossRefPubMed
9.
go back to reference van den Bosch AE, Robbers-Visser D, Krenning BJ, McGhie JS, Helbing WA, Meijboom FJ, Roos-Hesselink JW: Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass. Am J Cardiol. 2006, 97 (1): 113-117. 10.1016/j.amjcard.2005.07.114.CrossRefPubMed van den Bosch AE, Robbers-Visser D, Krenning BJ, McGhie JS, Helbing WA, Meijboom FJ, Roos-Hesselink JW: Comparison of real-time three-dimensional echocardiography to magnetic resonance imaging for assessment of left ventricular mass. Am J Cardiol. 2006, 97 (1): 113-117. 10.1016/j.amjcard.2005.07.114.CrossRefPubMed
10.
go back to reference Qin JX, Jones M, Travaglini A, Song JM, Li J, White RD, Tsujino H, Greenberg NL, Zetts AD, Panza JA, Thomas JD, Shiota T: The accuracy of left ventricular mass determined by real-time three-dimensional echocardiography in chronic animal and clinical studies: a comparison with postmortem examination and magnetic resonance imaging. J Am Soc Echocardiogr. 2005, 18 (10): 1037-1043. 10.1016/j.echo.2005.04.012.CrossRefPubMed Qin JX, Jones M, Travaglini A, Song JM, Li J, White RD, Tsujino H, Greenberg NL, Zetts AD, Panza JA, Thomas JD, Shiota T: The accuracy of left ventricular mass determined by real-time three-dimensional echocardiography in chronic animal and clinical studies: a comparison with postmortem examination and magnetic resonance imaging. J Am Soc Echocardiogr. 2005, 18 (10): 1037-1043. 10.1016/j.echo.2005.04.012.CrossRefPubMed
11.
go back to reference Loganathan R, Bilgen M, Al-Hafez B, Smirnova IV: Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging. 2006, 22 (1): 81-90. 10.1007/s10554-005-5386-6.CrossRefPubMed Loganathan R, Bilgen M, Al-Hafez B, Smirnova IV: Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging. 2006, 22 (1): 81-90. 10.1007/s10554-005-5386-6.CrossRefPubMed
13.
go back to reference Ren Y, Xu X, Wang X: Altered mRNA expression of ATP-sensitive and inward rectifier potassium channel subunits in streptozotocin-induced diabetic rat heart and aorta. J Pharmacol Sci. 2003, 93 (4): 478-483. 10.1254/jphs.93.478.CrossRefPubMed Ren Y, Xu X, Wang X: Altered mRNA expression of ATP-sensitive and inward rectifier potassium channel subunits in streptozotocin-induced diabetic rat heart and aorta. J Pharmacol Sci. 2003, 93 (4): 478-483. 10.1254/jphs.93.478.CrossRefPubMed
14.
go back to reference Sasso FC, Carbonara O, Persico E, D'Ambrosio R, Coppola L, Nasti R, Campana B, Moschella S, Torella R, Cozzolino D: Increased vascular endothelial growth factor mRNA expression in the heart of streptozotocin-induced diabetic rats. Metabolism. 2003, 52 (6): 675-678. 10.1016/S0026-0495(03)00064-7.CrossRefPubMed Sasso FC, Carbonara O, Persico E, D'Ambrosio R, Coppola L, Nasti R, Campana B, Moschella S, Torella R, Cozzolino D: Increased vascular endothelial growth factor mRNA expression in the heart of streptozotocin-induced diabetic rats. Metabolism. 2003, 52 (6): 675-678. 10.1016/S0026-0495(03)00064-7.CrossRefPubMed
15.
go back to reference Nagareddy PR, Vasudevan H, McNeill JH: Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol. 2005, 83 (5): 405-411. 10.1139/y05-026.CrossRefPubMed Nagareddy PR, Vasudevan H, McNeill JH: Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol. 2005, 83 (5): 405-411. 10.1139/y05-026.CrossRefPubMed
16.
go back to reference Searls YM, Smirnova IV, Fegley BR, Stehno-Bittel L: Exercise attenuates diabetes-induced ultrastructural changes in rat cardiac tissue. Med Sci Sports Exerc. 2004, 36 (11): 1863-1870. 10.1249/01.MSS.0000145461.38224.EC.CrossRefPubMed Searls YM, Smirnova IV, Fegley BR, Stehno-Bittel L: Exercise attenuates diabetes-induced ultrastructural changes in rat cardiac tissue. Med Sci Sports Exerc. 2004, 36 (11): 1863-1870. 10.1249/01.MSS.0000145461.38224.EC.CrossRefPubMed
17.
go back to reference Luan H, Leitges M, Gupta RR, Pacheco D, Seidner A, Liggett J, Ito Y, Kowluru R, Berkowitz BA: Effect of PKCbeta on retinal oxygenation response in experimental diabetes. Invest Ophthalmol Vis Sci. 2004, 45 (3): 937-942. 10.1167/iovs.03-1007.CrossRefPubMed Luan H, Leitges M, Gupta RR, Pacheco D, Seidner A, Liggett J, Ito Y, Kowluru R, Berkowitz BA: Effect of PKCbeta on retinal oxygenation response in experimental diabetes. Invest Ophthalmol Vis Sci. 2004, 45 (3): 937-942. 10.1167/iovs.03-1007.CrossRefPubMed
18.
go back to reference Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, Combe C, Moonen CW, Grenier N: Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging. 2003, 17 (1): 104-113. 10.1002/jmri.10224.CrossRefPubMed Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, Combe C, Moonen CW, Grenier N: Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging. 2003, 17 (1): 104-113. 10.1002/jmri.10224.CrossRefPubMed
19.
go back to reference Iltis I, Kober F, Desrois M, Dalmasso C, Lan C, Portha B, Cozzone PJ, Bernard M: Defective myocardial blood flow and altered function of the left ventricle in type 2 diabetic rats: a noninvasive in vivo study using perfusion and cine magnetic resonance imaging. Invest Radiol. 2005, 40 (1): 19-26.PubMed Iltis I, Kober F, Desrois M, Dalmasso C, Lan C, Portha B, Cozzone PJ, Bernard M: Defective myocardial blood flow and altered function of the left ventricle in type 2 diabetic rats: a noninvasive in vivo study using perfusion and cine magnetic resonance imaging. Invest Radiol. 2005, 40 (1): 19-26.PubMed
20.
go back to reference Khandheria BK: Noninvasive imaging. J Am Coll Cardiol. 2005, 45 (11 Suppl B): 17B-19B. 10.1016/j.jacc.2005.04.035.CrossRefPubMed Khandheria BK: Noninvasive imaging. J Am Coll Cardiol. 2005, 45 (11 Suppl B): 17B-19B. 10.1016/j.jacc.2005.04.035.CrossRefPubMed
22.
go back to reference Kapelko VI, Veksler VI, Popovich MI, Ventura-Clapier R: Energy-linked functional alterations in experimental cardiomyopathies. Am J Physiol. 1991, 261 (4 Suppl): 39-44.PubMed Kapelko VI, Veksler VI, Popovich MI, Ventura-Clapier R: Energy-linked functional alterations in experimental cardiomyopathies. Am J Physiol. 1991, 261 (4 Suppl): 39-44.PubMed
23.
go back to reference Iltis I, Kober F, Dalmasso C, Cozzone PJ, Bernard M: Noninvasive characterization of myocardial blood flow in diabetic, hypertensive, and diabetic-hypertensive rats using spin-labeling MRI. Microcirculation. 2005, 12 (8): 607-614. 10.1080/10739680500301607.CrossRefPubMed Iltis I, Kober F, Dalmasso C, Cozzone PJ, Bernard M: Noninvasive characterization of myocardial blood flow in diabetic, hypertensive, and diabetic-hypertensive rats using spin-labeling MRI. Microcirculation. 2005, 12 (8): 607-614. 10.1080/10739680500301607.CrossRefPubMed
24.
go back to reference Rodrigues B, Cam MC, Kong J, Goyal RK, McNeill JH: Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy. Cardiovasc Res. 1997, 34 (1): 199-205. 10.1016/S0008-6363(97)00045-X.CrossRefPubMed Rodrigues B, Cam MC, Kong J, Goyal RK, McNeill JH: Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy. Cardiovasc Res. 1997, 34 (1): 199-205. 10.1016/S0008-6363(97)00045-X.CrossRefPubMed
25.
go back to reference Ramanadham S, Doroudian A, McNeill JH: Myocardial and metabolic abnormalities in streptozotocin-diabetic Wistar and Wistar-Kyoto rats. Can J Cardiol. 1990, 6 (2): 75-82.PubMed Ramanadham S, Doroudian A, McNeill JH: Myocardial and metabolic abnormalities in streptozotocin-diabetic Wistar and Wistar-Kyoto rats. Can J Cardiol. 1990, 6 (2): 75-82.PubMed
26.
go back to reference Tomlinson KC, Gardiner SM, Hebden RA, Bennett T: Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev. 1992, 44 (1): 103-150.PubMed Tomlinson KC, Gardiner SM, Hebden RA, Bennett T: Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev. 1992, 44 (1): 103-150.PubMed
27.
go back to reference Hoit BD, Castro C, Bultron G, Knight S, Matlib MA: Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail. 1999, 5 (4): 324-333. 10.1016/S1071-9164(99)91337-4.CrossRefPubMed Hoit BD, Castro C, Bultron G, Knight S, Matlib MA: Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail. 1999, 5 (4): 324-333. 10.1016/S1071-9164(99)91337-4.CrossRefPubMed
28.
go back to reference Mihm MJ, Seifert JL, Coyle CM, Bauer JA: Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci. 2001, 69 (5): 527-542. 10.1016/S0024-3205(01)01141-9.CrossRefPubMed Mihm MJ, Seifert JL, Coyle CM, Bauer JA: Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci. 2001, 69 (5): 527-542. 10.1016/S0024-3205(01)01141-9.CrossRefPubMed
29.
go back to reference Iltis I, Kober F, Dalmasso C, Lan C, Cozzone PJ, Bernard M: In vivo assessment of myocardial blood flow in rat heart using magnetic resonance imaging: effect of anesthesia. J Magn Reson Imaging. 2005, 22 (2): 242-247. 10.1002/jmri.20352.CrossRefPubMed Iltis I, Kober F, Dalmasso C, Lan C, Cozzone PJ, Bernard M: In vivo assessment of myocardial blood flow in rat heart using magnetic resonance imaging: effect of anesthesia. J Magn Reson Imaging. 2005, 22 (2): 242-247. 10.1002/jmri.20352.CrossRefPubMed
30.
go back to reference Shizukuda Y, Reyland ME, Buttrick PM: Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol Heart Circ Physiol. 2002, 282 (5): H1625-34.CrossRefPubMed Shizukuda Y, Reyland ME, Buttrick PM: Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol Heart Circ Physiol. 2002, 282 (5): H1625-34.CrossRefPubMed
31.
go back to reference Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Lab Invest. 2000, 80 (4): 513-527.CrossRefPubMed Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent. Lab Invest. 2000, 80 (4): 513-527.CrossRefPubMed
32.
go back to reference Tschope C, Walther T, Koniger J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M: Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. Faseb J. 2004, 18 (7): 828-835. 10.1096/fj.03-0736com.CrossRefPubMed Tschope C, Walther T, Koniger J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M: Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. Faseb J. 2004, 18 (7): 828-835. 10.1096/fj.03-0736com.CrossRefPubMed
33.
go back to reference Fein FS, Miller-Green B, Sonnenblick EH: Altered myocardial mechanics in diabetic rabbits. Am J Physiol. 1985, 248 (5 Pt 2): H729-36.PubMed Fein FS, Miller-Green B, Sonnenblick EH: Altered myocardial mechanics in diabetic rabbits. Am J Physiol. 1985, 248 (5 Pt 2): H729-36.PubMed
34.
go back to reference Shen X, Ye G, Metreveli NS, Epstein PN: Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Methods Mol Med. 2005, 112: 379-388.PubMed Shen X, Ye G, Metreveli NS, Epstein PN: Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Methods Mol Med. 2005, 112: 379-388.PubMed
35.
go back to reference Severson DL: Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol. 2004, 82 (10): 813-823. 10.1139/y04-065.CrossRefPubMed Severson DL: Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol. 2004, 82 (10): 813-823. 10.1139/y04-065.CrossRefPubMed
Metadata
Title
Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging
Authors
Rajprasad Loganathan
Mehmet Bilgen
Baraa Al-Hafez
Mohammed D Alenezy
Irina V Smirnova
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2006
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-5-7

Other articles of this Issue 1/2006

Cardiovascular Diabetology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.